HTG Molecular Diagnostics: Funding, Investors & Team (Oct 2026)
HTG Molecular Diagnostics is a leading provider of molecular-based technology solutions for gene expression profiling, miRNA, siRNA and mRNA measurement for translational medicine and diagnostic applications. The Company's qNPA molecular technology platform is well-suited for reliably detecting small, yet important, changes in gene expression levels in a variety of sample types. Privately-held HTG is based Tucson, Arizona.
HTG Molecular Diagnostics has raised $7.5M across 1 funding round on record, the most recent a Post-IPO Equity of $7.5M announced in Mar 2022.
That round is in line with the $8.1M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
HTG Molecular Diagnostics Company Profile and Key Stats
Latest funding round on record: Mar 2022.
HTG Molecular Diagnostics Funding Rounds
HTG Molecular Diagnostics Founders and Leadership Team
Contact details for the HTG Molecular Diagnostics team: 1 of 1 has an email address on file.
Start 14-day free trial →HTG Molecular Diagnostics Funding Compared to Other Biotechnology Startups
HTG Molecular Diagnostics' latest round of $7.5M is in line with the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like HTG Molecular Diagnostics in Biotechnology and Tucson
Companies Similar to HTG Molecular Diagnostics
Kallyope, we believe that the gut is the gateway to our internal world. Containing millions of neurons, the…
Astrocyte Pharmaceuticals is a drug development company that helps in the recovery and well-being of brain…
Tiny Health offers a gut health test specifically designed for mothers and babies aged 0 to 3 years.…
Junevity is dedicated to using cutting-edge transcription factor medicines to combat age-related diseases.…
Arkea Bio creates technology aimed at reducing greenhouse gas (GHG) emissions in the agricultural sector.
Serán is a contract development and manufacturing organization providing a comprehensive suite of…
Precision’s goal is to provide breakthrough treatments for the one billion patients worldwide suffering from…
Enveda is a biotechnology company that utilizes AI-powered tools to explore and characterize molecules from…
Avery Therapeutics, Inc. is a company dedicated to developing tissue engineered therapeutics to treat…
Circle Pharma is a biotechnology company in the initial stages of development that uses unique computational…
Evvy is for people with vaginas who want to be empowered with information about their microbiome. Their…
HTG Molecular Diagnostics Funding FAQs
What does HTG Molecular Diagnostics do?
HTG Molecular Diagnostics is a leading provider of molecular-based technology solutions for gene expression profiling, miRNA, siRNA and mRNA measurement for translational medicine and diagnostic applications. The Company's qNPA molecular technology platform is well-suited for reliably detecting small, yet important, changes in gene expression levels in a variety of sample types. Privately-held HTG is based Tucson, Arizona.
How much funding has HTG Molecular Diagnostics raised?
HTG Molecular Diagnostics has raised $7.5M across 1 round on record. The most recent is a Post-IPO Equity of $7.5M announced in Mar 2022.
When did HTG Molecular Diagnostics last raise funding?
HTG Molecular Diagnostics' most recent funding round on record is a Post-IPO Equity of $7.5M, announced in Mar 2022.
Who is the CEO of HTG Molecular Diagnostics?
John Lubniewski is listed as CEO at HTG Molecular Diagnostics.
Where is HTG Molecular Diagnostics headquartered?
HTG Molecular Diagnostics is based in Tucson, Arizona, United States.
How many employees does HTG Molecular Diagnostics have?
HTG Molecular Diagnostics is in the 101-250 employee band.
How does HTG Molecular Diagnostics' funding compare to other Biotechnology startups?
HTG Molecular Diagnostics' latest round of $7.5M is in line with the $8.1M median round size for Biotechnology companies on FundedIQ across 4,185 tracked companies over the last two years.
About FundedIQ's HTG Molecular Diagnostics Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for HTG Molecular Diagnostics is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.
Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.